National MCO Analyzer

Highmark | 2021 | National MCO Analyzer Brief

Highmark, along with 17 other Blue Cross Blue Shield organizations, invested $55 million to create their own nonprofit drug company with CivicaRx in 2020 to make alternatives to high-cost generic